Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,334 authorised products are in this register. Synced 17 Sep 2026, 07:59 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Baqsimi 3 mg nasal powder in single-dose container EU/1/19/1406/001-002

GLUCAGON

Amphastar France Pharmaceuticals, S.A.S.

—

Bisolvon 4mg/5ml Oral Solution PA23180/015/001

Bromhexine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Not marketed

Buscopan 10 mg Coated Tablets PA23180/016/002

Hyoscine butylbromide

Opella Healthcare France SAS T/A Sanofi

Marketed

Buscopan Ampoules 20 mg/ml Solution for Injection PA23180/016/001

Hyoscine butylbromide

Opella Healthcare France SAS T/A Sanofi

Not marketed

Buscopan Rx 10mg Coated Tablets PA23180/022/001

Hyoscine butylbromide

Opella Healthcare France SAS T/A Sanofi

Not marketed

ChloraPrep 2% w/v/ 70% v/v cutaneous solution PA2287/001/002

Chlorhexidine gluconate, Isopropyl alcohol

Becton Dickinson France

Marketed

ChloraPrep 2% w/v/70% v/v impregnated cutaneous swab PA2287/001/003

Chlorhexidine digluconate, Isopropyl alcohol

Becton Dickinson France

Marketed

ChloraPrep with Tint 2% w/v/70% v/v cutaneous solution PA2287/001/001

Chlorhexidine gluconate, Isopropyl alcohol

Becton Dickinson France

Marketed

Dulcolax 10 mg Suppositories PA23180/018/002

Bisacodyl

Opella Healthcare France SAS T/A Sanofi

Marketed

Dulcolax 5mg Gastro-resistant Tablets PA23180/018/003

Bisacodyl

Opella Healthcare France SAS T/A Sanofi

Marketed

Dulcolax Pico Liquid 5 mg/5 ml oral solution PA23180/017/001

Sodium picosulfate

Opella Healthcare France SAS T/A Sanofi

Marketed

Ferinject 50 mg iron/mL dispersion for injection/infusion PA0949/004/001

IRON CARBOXYMALTOSE

Marketed

Filspari 200 mg film-coated tablets EU/1/23/1788/001

Sparsentan

—

Filspari 400 mg film-coated tablets EU/1/23/1788/002-003

Sparsentan

—

GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe PA22641/002/002

Lenograstim

Chugai Pharma France

Marketed

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe PA22641/002/001

Lenograstim

Chugai Pharma France

Marketed

Idrolax 10g, powder for oral solution in a sachet PA22808/001/001

Macrogol 4000

Mayoly Pharma France

Not marketed

Kapruvia 50 micrograms/mL solution for injection EU/1/22/1643/001-002

Difelikefalin Acetate

—

Latuda 18.5 mg film-coated tablets EU/1/14/913/001-007

Lurasidone hydrochloride

Aziende Chimiche Riunite Angelini Francesco

—

Latuda 37 mg film-coated tablets EU/1/14/913/008-014

Lurasidone hydrochloride

Aziende Chimiche Riunite Angelini Francesco

—

Latuda 74 mg film-coated tablets EU/1/14/913/015-021

Lurasidone hydrochloride

Aziende Chimiche Riunite Angelini Francesco

—

Maalox 200mg/175mg per 5ml Oral Suspension PA23180/009/001

Magnesium hydroxide, Aluminium hydroxide

Opella Healthcare France SAS T/A Sanofi

Marketed

Maalox 400mg/400mg Chewable Tablets PA23180/009/002

Magnesium hydroxide, Aluminium oxide, hydrated

Opella Healthcare France SAS T/A Sanofi

Marketed

Maalox Plus 200 mg/175 mg/25 mg Oral Suspension PA23180/008/001

Aluminium hydroxide, Magnesium hydroxide, Simeticone

Opella Healthcare France SAS T/A Sanofi

Marketed

Maalox Plus Chewable Tablets 200 mg/200 mg/25 mg PA23180/008/002

ALUMINIUM OXIDE, HYDRATED PH. EUR, MAGNESIUM HYDROXIDE PH. EUR., Dimeticone ph. eur. (as simeticone ph. eur.)

Opella Healthcare France SAS T/A Sanofi

Marketed

NASACORT 55 micrograms/dose, nasal spray, suspension PA23180/001/001

Triamcinolone acetonide

Opella Healthcare France SAS T/A Sanofi

Marketed

Nasacort Allergy 55 micrograms/dose nasal spray, suspension PA23180/001/002

Triamcinolone acetonide

Opella Healthcare France SAS T/A Sanofi

Marketed

Phenergan 25 mg film-coated tablets PA23180/011/002

Promethazine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Marketed

Phenergan 5 mg/5 ml oral solution PA23180/011/001

Promethazine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Marketed

Pylclari 1000 MBq/mL solution for injection EU/1/23/1746/001

2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid

Curium Pet France

—

Selsun Shampoo 2.5% w/v PA23180/013/001

Selenium disulfide

Opella Healthcare France SAS T/A Sanofi

Not marketed

TAVNEOS 10 mg Capsule, hard EU/1/21/1605/001-002

Avacopan

Vifor Fresenius Medical Care Renal Pharma France

—

Telfast 120 mg film-coated tablets PA23180/003/002

Fexofenadine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Marketed

Telfast 180 mg film-coated tablets PA23180/003/003

Fexofenadine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Marketed

Telfast 30 mg film-coated tablets PA23180/003/001

Fexofenadine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Not marketed

Telfast Allergy 120 mg film-coated tablets PA23180/014/001

Fexofenadine hydrochloride

Opella Healthcare France SAS T/A Sanofi

Marketed

Velphoro 125 mg oral powder in sachet EU/1/14/943/005

Sucroferric Oxyhydroxide

Vifor Fresenius Medical Care Renal Pharma France

—

Velphoro 500 mg chewable tablets EU/1/14/943/001-004

Mixture of iron(iii)-oxyhydroxide, sucrose, starches

Vifor Fresenuis Medical Care Renal Pharma France

—

Veltassa 1 g powder for oral suspension EU/1/17/1179/011

Patiromer sorbitex calcium

Vifor Fresenius Medical Care Renal Pharma France

—

Veltassa 16.8 g powder for oral suspension EU/1/17/1179/004-006

Patiromer sorbitex calcium

Vifor Fresenius Medical Care Renal Pharma France

—

Veltassa 25.2 g powder for oral suspension EU/1/17/1179/007-008

Patiromer sorbitex calcium

Vifor Fresenius Medical Care Renal Pharma France

—

Veltassa 8.4 g powder for oral suspension EU/1/17/1179/001-003

Patiromer sorbitex calcium

Vifor Fresenius Medical Care Renal Pharma France

—

Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, ampoule PA0949/001/001

IRON (III)

Not marketed

Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, vial PA0949/001/002

Iron (iii) - hydroxide sucrose complex

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 20 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.